Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:50:48 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:AYTU - AYTU BIOPHARMA INC - https://aytubio.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AYTU - Q3.02.33·2.623.32.39+0.093.942.9902312.30  2.50  2.28263.065  0.9516:10:04Feb 0315 min RT 2¢

Recent Trades - Last 10 of 231
Time ETExPriceChangeVolume
16:10:04Q2.390.091
16:10:04Q2.390.091
16:04:39Q2.390.091
16:04:06Q2.390.091
16:00:03Q2.390.094
16:00:03Q2.390.0975
16:00:03Q2.390.099
16:00:03Q2.390.09140
16:00:03Q2.390.093
16:00:03Q2.390.091

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-03 16:05U:AYTUNews ReleaseAytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
2026-01-27 16:05U:AYTUNews ReleaseAytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026
2026-01-20 16:05U:AYTUNews ReleaseAytu BioPharma Recaps Investor Day Held on January 20, 2026
2026-01-20 09:00U:AYTUNews ReleaseAytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA
2026-01-13 16:15U:AYTUNews ReleaseAytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
2026-01-12 08:00U:AYTUNews ReleaseAytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City
2025-12-18 09:00U:AYTUNews ReleaseAytu BioPharma to Host Investor Day on January 20, 2026 in New York City
2025-12-15 09:00U:AYTUNews ReleaseAytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
2025-11-24 16:05U:AYTUNews ReleaseAytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
2025-11-13 16:05U:AYTUNews ReleaseAytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
2025-11-05 16:05U:AYTUNews ReleaseAytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
2025-10-28 09:00U:AYTUNews ReleaseAytu BioPharma Announces Patent Term Extension for EXXUA(TM)
2025-10-10 09:00U:AYTUNews ReleaseAytu BioPharma to Present at Upcoming October 2025 Conferences
2025-09-25 08:00U:AYTUNews Release11 Company Presentations Today at The MicroCap Rodeo Conference
2025-09-24 16:15U:AYTUNews ReleaseAytu BioPharma to Present at Upcoming September 2025 Conferences
2025-09-23 16:05U:AYTUNews ReleaseAytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
2025-09-16 16:05U:AYTUNews ReleaseAytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
2025-06-25 08:00U:AYTUNews ReleaseAytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)
2025-06-23 08:00U:AYTUNews ReleaseAytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)
2025-06-09 16:30U:AYTUNews ReleaseAytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan